This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Kaftrio - Tezacaftor with Ivacaftor and Elexacaftor

Vertex

Description

Mucolytic to facilitate expectoration by reducing sputum viscosity in the case of cystic fibrosis.

Kaftrio 37.5 mg/25 mg/500 mg
Child 6–11 years (body-weight up to 30 kg): 2 tablets, to be taken in the morning and, Ivacaftor 75 mg to be taken in the evening (about 12 hours apart).

Kaftrio 75 mg/50 mg/100 mg
Child over 6 years with body weight greater than 30 kgs and adult: 2 tablets to be taken in the morning in combination with Ivacaftor 150 mg in the evening.

Indications

Mucolytic to facilitate expectoration by reducing sputum viscosity in the case of cystic fibrosis.

Preparations Available

Tablets

Sizes Available

Tablets
Kaftrio 37.5 mg/25 mg/500 mg, 56 tablets
Kaftrio 75 mg/50 mg/100 mg, 56 tablets

More on: Mucolytics , Tezacaftor with Ivacaftor and Elexacaftor